(NPR) Coronavirus Vaccine From Oxford-AstraZeneca Shows Promising Results In Early Human Trial

Coronavirus Vaccine From Oxford-AstraZeneca Shows Promising Results In Early Human Trial








An experimental vaccine candidate being developed by AstraZeneca and Oxford University to protect against COVID-19 triggered an immune response against the coronavirus and appeared to be safe.



Paul Ellis/AFP via Getty Images


hide caption





toggle caption




Paul Ellis/AFP via Getty Images











Coronavirus Vaccine From Oxford-AstraZeneca Shows Promising Results In Early Human Trial






Testing in more than 1,000 people found the vaccine spurred an immune response and had no severe side effects. Larger trials are underway.








Loading...